Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: Results of RTOG 9505
- Division of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN (United States)
- Department of Anatomic Pathology, University of California-San Diego, San Diego, CA (United States)
- Statistics, RTOG Headquarters, Philadelphia, PA (United States)
- Department of Pathology, LDS Hospital, Intermountain Health Care and University of Utah School of Medicine, Salt Lake City, UT (United States)
- Division of Anatomic Pathology, Mayo Clinic College of Medicine, Rochester, MN (United States)
- Department of Radiation Oncology, McGill University, Montreal, Quebec (Canada)
- Department of Radiation Oncology, M.D. Anderson Cancer Center, Houston, TX (United States)
- Department of Radiation Oncology, University of California, San Francisco, CA (United States)
Purpose: The objective of this study was to evaluate tumor angiogenesis as measured by microvessel density (MVD) as an independent prognostic factor in patients with nasopharyngeal carcinoma (NPC) treated with radiotherapy alone. Methods and materials: Eligible patients included those with NPC treated with radiotherapy. Paraffin blocks of the primary tumor had a hematoxylin and eosin-stained section prepared at the block face. One representative section for tumor was stained for factor VIII-related antigen using a standard immunoperoxidase staining technique. MVD was determined by light microscopy in areas of invasive tumor containing the highest numbers of capillaries and microvessels per area. Individual microvessel counts were made on a 200x field within the area of most intense tumor neovascularization. Results were expressed as the highest number of microvessels identified within any single 200x field. Using a breakpoint of MVD < 60 vs. {>=}60, the distributions between the two MVD groups were compared by the method of Gray. Overall survival rates were estimated by the Kaplan-Meier method and compared by the log-rank test. A multivariate Cox proportional hazard model was employed to examine the relationship between MVD and disease outcomes while adjusting for other concomitant variables. Results: One hundred sixty-six were eligible, of whom 123 had values determined for MVD. The MVD values ranged from 9 to 243 with a median of 70. In the multivariate analysis of overall survival, distant metastases, and local-regional failure, MVD did not significantly improve the model containing T stage, N stage, age, radiation dose, and World Health Organization class. Conclusions: We found no significant differences in overall survival, time to distant metastasis, or time to local-regional failure using a breakpoint of MVD < 60 vs. MVD {>=}60. The study was perhaps limited by the small size of the NPC samples.
- OSTI ID:
- 20633083
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 61, Issue 3; Other Information: DOI: 10.1016/j.ijrobp.2004.07.694; PII: S0360-3016(04)02088-7; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model
Study of the Impact of Uterine Artery Embolization (UAE) on Endometrial Microvessel Density (MVD) and Angiogenesis